Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
187 studies found for:    "Poliomyelitis"
Show Display Options
Rank Status Study
1 Completed The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains
Condition: Poliomyelitis
Intervention: Biological: Inactivated Poliomyelitis Vaccine (Sabin strains)
2 Completed The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)
Condition: Poliomyelitis
Interventions: Biological: Inactivated Poliomyelitis Vaccine (Sabin strains);   Biological: Oral Poliomyelitis Vaccine;   Biological: Inactivated Poliomyelitis Vaccine (Salk strains).
3 Completed The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)
Condition: Poliomyelitis
Interventions: Biological: Inactivated Poliomyelitis Vaccine (Sabin strains);   Biological: Inactivated Poliomyelitis Vaccine (Salk strains)
4 Completed The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)
Condition: Poliomyelitis
Interventions: Biological: Live attenuated Poliomyelitis vaccine (Human Diploid Cell);   Biological: Live attenuated Poliomyelitis vaccine (Monkey Kidney Cell)
5 Completed Safety of Imovax Polio in Chinese Infants and Children
Condition: Poliomyelitis
Intervention: Biological: Inactivated Poliomyelitis vaccine
6 Completed Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix™) in Infants
Condition: Poliomyelitis
Intervention: Biological: Poliorix™
7 Completed Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine
Condition: Poliomyelitis
Interventions: Biological: TiantanBio bOPV lot 1;   Biological: TiantanBio bOPV lot 2;   Biological: Bivalent Type 1 & 3 Oral Poliomyelitis Vaccine (BioFarma)
8 Completed Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine
Conditions: Polio;   Poliomyelitis
Interventions: Biological: Injectable inactivated types 1, 2 and 3 poliovirus + Live oral Polio;   Biological: Live oral poliovirus type 1, 2 and 3
9 Completed Immunogenicity and Safety of 3 Adjuvated Reduced Dose Inactivated Polio Vaccines (IPV-Al SSI) and Non-adjuvated Full Dose IPV SSI, Given as Primary Vaccinations to Infants at 6, 10 and 14 Weeks of Age
Condition: Poliomyelitis
Interventions: Biological: Primary series of immunisation comprised by 3 vaccinations IPV-Al SSI;   Biological: IPV Vaccine SSI
10 Completed Immunogenicity of Inactivated and Live Polio Vaccines
Condition: Poliomyelitis
Interventions: Biological: Group A: Trivalent Oral Polio Vaccine;   Biological: Group B: Bivalent Oral Polio Vaccine;   Biological: Group C: Inactivated Polio Vaccine;   Biological: Group D: fractional IPV (f-IPV);   Biological: Arm E: f-IPV and bOPV
11 Completed Comparison of Immune Response Using 2 Vaccination Schedules Using Inactivated Polio Vaccine
Condition: Poliomyelitis
Interventions: Biological: Vaccination with inactivated polio vaccine;   Procedure: Collection of serum
12 Completed Polio End-game Strategies - Poliovirus Type 2 Challenge Study
Condition: Poliomyelitis
Interventions: Biological: IPV;   Biological: bOPV;   Biological: bOPV and IPV;   Biological: bOPV and IPV and IPV2;   Biological: tOPV
13 Completed A Study of the Safety of IMOVAX Polio™ in China
Conditions: Poliomyelitis;   Polio
Intervention: Biological: IMOVAX Polio™-Inactivated types 1, 2, and 3 poliovirus D vaccine
14 Completed Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan
Condition: Poliomyelitis
Interventions: Drug: Zinc Sulfate;   Drug: Placebo
15 Completed A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China
Conditions: Polio;   Poliomyelitis
Intervention: Biological: IMOVAX Polio™: Inactivated Poliomyelitis Vaccine
16 Completed
Has Results
Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan
Conditions: Poliomyelitis;   Polio
Intervention: Biological: IMOVAX POLIO®: Inactive Poliovirus Vaccine
17 Completed Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly
Condition: Poliomyelitis
Intervention: Biological: Inactivated Poliomyelitis vaccine (IMOVAX)
18 Completed Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly
Condition: Poliomyelitis
Intervention: Biological: Inactivated types 1, 2, and 3 poliovirus, D antigens
19 Completed Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine
Condition: Poliomyelitis
Intervention: Biological: poliovirus vaccine
20 Completed Safety and Immunogenicity of a New Inactivated Polio Vaccine in Healthy Adults
Condition: Poliomyelitis
Interventions: Drug: IPV;   Drug: Sabin-IPV;   Drug: Adjuvanted Sabin-IPV

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.